-
FDA Receives Vepdegestrant NDA for ESR1-Mutated Breast Cancer
07 Jun 2025 00:11 GMT
… the treatment of patients with estrogen receptor (ER)-positive, HER2-negative … +/HER2- advanced or metastatic breast cancer.
REFERENCES:
1. Arvinas announces submission … , et al. Vepdegestrant, a PROTAC estrogen receptor (ER) degrader, vs fulvestrant …
-
14 out of 100 women who take part in common habit every week will develop breast cancer: experts
06 Jun 2025 22:07 GMT
… glasses — will be diagnosed with breast cancer during their lifetime, according to … breast cancer, according to Medical News Today.
Alcohol also ramps up estrogen levels … and development. More estrogen means a higher risk of breast cancer.
And don …
-
FDA Receives NDA for Vepdegestrant in ESR1-Mutated, ER+/HER2– Metastatic Breast Cancer
06 Jun 2025 18:18 GMT
… with estrogen receptor (ER)–positive, HER2-negative advanced or metastatic breast cancer harboring … #47;HER2- advanced or metastatic breast cancer. News release. Arvinas. June … receptor 2 (HER2)–negative advanced breast cancer: results of the global, …
-
Dr Rugo on Research Needed to Clarify the Role of T-DXd Plus Pertuzumab in HER2+ Breast Cancer
06 Jun 2025 18:18 GMT
… HER2-positive advanced/metastatic breast cancer.
Findings from DESTINY-Breast09 presented … patients with HER2-positive early breast cancer.
The reported improvement in … potential use for patients with estrogen receptor–positive disease, highlighting the …
-
Empowering women: The revolutionary breast cancer prevention diet unveiled in Bob Arnot’s book
06 Jun 2025 17:42 GMT
… approach to reducing breast cancer risk through diet … beyond breast cancer prevention.
In a world where breast cancer … The journey toward understanding breast cancer prevention began decades … crucial role in breast cancer development. Estrogen acts like fuel …
-
Pfizer, Arvinas Partnered Breast Cancer Drug Cuts Progression Risk By 43% In Trial, Seeks FDA Approval
06 Jun 2025 14:56 GMT
… -) ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based … (PFS) among patients with an estrogen receptor 1 (ESR1) mutation, reducing …
-
Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer
06 Jun 2025 11:00 GMT
… ESR1-mutated advanced or metastatic breast cancer previously treated with endocrine-based … ;HER2- advanced or metastatic breast cancer with estrogen receptor 1 (ESR1) mutations … HER2- advanced or metastatic breast cancer previously treated with endocrine-based …
-
Why does Breast Cancer happen? 5 biggest triggers
06 Jun 2025 05:47 GMT
… developing breast cancer. These mutations often lead to breast cancer … estrogen, a hormone that can fuel some breast cancers. … hormones can impact breast cancer development.Metabolic Health … the chance of developing breast cancer, especially after menopause …
-
Targeting Trophoblast Antigen in Triple-Negative Breast Cancer
06 Jun 2025 01:59 GMT
… realm of breast cancer research, triple-negative breast cancer (TNBC) … by the absence of estrogen receptor (ER), progesterone … studiesprecision medicine in breast cancerretrospective analysis of … in cancertriple-negative breast cancer treatment optionsTROP-2 …
-
NRG Oncology Study Finds Regional Nodal Irradiation Does Not Lower Invasive Breast Cancer Recurrence in Patients with Axillary Node Conversion After Neoadjuvant Chemotherapy
06 Jun 2025 01:59 GMT
… receptor status including estrogen (ER) and progesterone … Keywords: Medical specialties, breast cancer, regional nodal irradiation … trials, invasive breast cancer recurrence Tags: axillary … trial outcomesinvasive breast cancer recurrence ratesneoadjuvant …
About
© 1995-2025